Renaissance Technologies’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$517K Buy
190,673
+67,900
+55% +$184K ﹤0.01% 2813
2025
Q1
$416K Sell
122,773
-24,400
-17% -$82.7K ﹤0.01% 2815
2024
Q4
$606K Buy
147,173
+11,300
+8% +$46.6K ﹤0.01% 2758
2024
Q3
$338K Sell
135,873
-900
-0.7% -$2.24K ﹤0.01% 2938
2024
Q2
$361K Buy
136,773
+49,704
+57% +$131K ﹤0.01% 2839
2024
Q1
$179K Buy
87,069
+17,896
+26% +$36.8K ﹤0.01% 3249
2023
Q4
$125K Buy
69,173
+7,200
+12% +$13K ﹤0.01% 3246
2023
Q3
$85K Buy
61,973
+1,600
+3% +$2.2K ﹤0.01% 3279
2023
Q2
$83K Buy
60,373
+28,200
+88% +$38.8K ﹤0.01% 3513
2023
Q1
$76K Buy
32,173
+2,500
+8% +$5.91K ﹤0.01% 3568
2022
Q4
$68K Sell
29,673
-2,200
-7% -$5.04K ﹤0.01% 3728
2022
Q3
$88K Sell
31,873
-300
-0.9% -$828 ﹤0.01% 3633
2022
Q2
$79K Buy
32,173
+13,700
+74% +$33.6K ﹤0.01% 3902
2022
Q1
$73K Buy
18,473
+4,800
+35% +$19K ﹤0.01% 3846
2021
Q4
$60K Sell
13,673
-25,990
-66% -$114K ﹤0.01% 3763
2021
Q3
$245K Buy
39,663
+18,556
+88% +$115K ﹤0.01% 3137
2021
Q2
$167K Sell
21,107
-5,944
-22% -$47K ﹤0.01% 3281
2021
Q1
$289K Sell
27,051
-16,200
-37% -$173K ﹤0.01% 3066
2020
Q4
$666K Buy
43,251
+1,132
+3% +$17.4K ﹤0.01% 2698
2020
Q3
$720K Buy
42,119
+6,826
+19% +$117K ﹤0.01% 2674
2020
Q2
$291K Buy
35,293
+9,886
+39% +$81.5K ﹤0.01% 3053
2020
Q1
$178K Buy
25,407
+88
+0.3% +$617 ﹤0.01% 3120
2019
Q4
$264K Buy
25,319
+4,084
+19% +$42.6K ﹤0.01% 3099
2019
Q3
$237K Sell
21,235
-1,513
-7% -$16.9K ﹤0.01% 3096
2019
Q2
$414K Buy
22,748
+11,531
+103% +$210K ﹤0.01% 3068
2019
Q1
$812K Sell
11,217
-1,772
-14% -$128K ﹤0.01% 2760
2018
Q4
$374K Sell
12,989
-986
-7% -$28.4K ﹤0.01% 2956
2018
Q3
$1.18M Buy
13,975
+3,109
+29% +$261K ﹤0.01% 2536
2018
Q2
$1.37M Buy
10,866
+4,762
+78% +$600K ﹤0.01% 2462
2018
Q1
$554K Buy
6,104
+922
+18% +$83.7K ﹤0.01% 2876
2017
Q4
$379K Buy
5,182
+522
+11% +$38.2K ﹤0.01% 2952
2017
Q3
$437K Buy
4,660
+1,172
+34% +$110K ﹤0.01% 2826
2017
Q2
$367K Buy
3,488
+950
+37% +$100K ﹤0.01% 2843
2017
Q1
$343K Buy
2,538
+321
+14% +$43.4K ﹤0.01% 2870
2016
Q4
$351K Buy
2,217
+884
+66% +$140K ﹤0.01% 2869
2016
Q3
$330K Buy
1,333
+1,248
+1,468% +$309K ﹤0.01% 2932
2016
Q2
$76K Sell
85
-21
-20% -$18.8K ﹤0.01% 3196
2016
Q1
$96K Sell
106
-154
-59% -$139K ﹤0.01% 3220
2015
Q4
$368K Buy
+260
New +$368K ﹤0.01% 2826